Educational Resources

Desmoid Tumor ICD-10-CM Codes Flashcard

FDA-Approved Therapy and ICD-10-CM Codes for Desmoid Tumors. Desmoid tumors are rare, locally aggressive soft tissue tumors that are characterized by high rates of initial misdiagnosis.
View Resource

Posted on 11/20/2024

2025 Inflation Reduction Act (IRA) FRM

Changes to Medicare Part D in 2025 will Cap Out-Of-Pocket (OOP) Costs for Patients. Please feel free to review & share this important resource.
View Resource

Posted on 11/13/2024

Johnson and Johnson 2023 U.S. Pricing Transparency Report

Johnson and Johnson’s eighth U.S. Pricing Transparency Report provides key data, analysis and insights that will help advance solutions to create a more sustainable, equitable and innovative healthcare system.
View Resource

Posted on 11/09/2024

Anemia in Focus: The Challenge of Identifying Myelodysplastic Syndromes (MDS)

Anemia is a hallmark of MDS, conferring heightened mortality risk and diminished quality of life. Please feel free to view & share this important resource.
View Resource

Posted on 11/09/2024

Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups

Published on November 11, 2024

Elacestrant significantly prolonged progression-free survival (PFS) with manageable safety versus standard-of-care (SOC) endocrine therapy (ET) in patients with estrogen receptor–positive (ER+), HER2− metastatic breast cancer and tumors harboring estrogen receptor 1 (ESR1) mutation following ET plus a cyclin-dependent kinase 4/6 inhibitor (ET+CDK4/6i).
View Resource

ADC Cast is a Non-Promotional Educational Podcast Series Dedicated to Antibody Drug Conjugates (ADCs) in Breast Cancer

Hosted by Dr Javier Cortés and Prof. Peter Schmid, joined by an international panel of experts in ADCs and breast cancer, this educational podcast series unveils invaluable insights into ADCs, shedding light on their developmental history, their distinctive structural features and mechanisms of action, as well as potential future advancements.

Posted on 10/16/2024

Listen Here

Learn How LAG-3 Helps Tumors Evade the Immune System and Why Inhibiting It May Enhance Existing Immunotherapies

Published: September 26, 2024

Could targeting LAG-3 take cancer immunotherapy to the next level? Dr. Sabi Pabla and Dr. Eric Severson share insights on this promising immune biomarker in the latest Labcorp Perspectives: Oncology interview.
Listen Here

Small Moments Can Help You Spot Endometrial Cancer

Published: August 12, 2024

Too often, women with endometrial cancer (EC) have reported that their symptoms were stigmatized and dismissed. Even though diagnoses and deaths from this type of uterine cancer are on the rise, EC remains under-recognized.

Spot Her® is an initiative to help end the silence around EC and empower all people across generations and cultures to speak up, take action, and spot the potential signs at an early stage—when EC may be more treatable.
Learn More

A Toolkit For Those Living With or Care For Someone with Diffuse Large B-Cell Lymphoma (DLBCL)

Published: August 8, 2024

The purpose of this Toolkit is to help support your experience as someone living with Diffuse Large B-Cell Lymphoma (DLBCL) or as a care partner by providing information to help you build a deeper understanding of DLBCL. This Toolkit was created by a group of patients, care partners, advocates and healthcare professionals brought together by Incyte, a pharmaceutical company working on behalf of the DLBCL community.
View Resource

Implementing a Quality Intervention for Patients with Clinical Characteristics of Advanced Polycythemia Vera

Published on: July 30, 2024

This resource is a guide for pharmacy directors and clinical pharmacists to help clinicians identify the subset of patients with clinical characteristics of advanced polycythemia vera (PV).
View Resource